Literature DB >> 18494377

G6PD deficient alleles and haplotype analysis of human G6PD locus in São Tomé e Príncipe (West Africa).

Licínio Manco1, Laura R Botigué, M Letícia Ribeiro, Augusto Abade.   

Abstract

A population sample from São Tomé e Príncipe (West Africa) was screened for the G6PD-deficient variants A- (376G/202A), Betica (376G/968C), and Santa Maria (376G/542T). G6PD locus haplotype diversity was also investigated using six intragenic RFLPs (FokI, PvuII, BspHI, PstI, BclI, NlaIII) and a (CTT)n microsatellite 18.61 kb within the G6PD locus. The estimated frequencies of the G6PD*B normal allele, the G6PD*A variant (376G), and the G6PD*A- allele were 0.698, 0.194, and 0.108, respectively. G6PD variants Betica and Santa Maria were not found. Similar levels of microsatellite diversity were found on variants G6PD*B and G6PD*A (H = 0.61 and 0.68, respectively), indicating a similar age for both alleles. All G6PD*A- alleles share the RFLP-microsatellite haplotype ++(-)+(-)+/195, the same haplotype described in nearly all the *A-alleles from sub-Saharan, Mexican Mestizo, and Portuguese populations, consistent with a single and recent origin of the G202A mutation on this *A haplotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18494377     DOI: 10.1353/hub.2008.0013

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  4 in total

1.  PharmGKB summary: very important pharmacogene information for G6PD.

Authors:  Ellen M McDonagh; Caroline F Thorn; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-03       Impact factor: 2.089

Review 2.  Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.

Authors:  Judith Recht; Elizabeth A Ashley; Nicholas J White
Journal:  PLoS Negl Trop Dis       Date:  2018-04-19

3.  G6PD variant distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.

Authors:  Jorge da Rocha; Houcemeddine Othman; Caroline T Tiemessen; Gerrit Botha; Michele Ramsay; Collen Masimirembwa; Clement Adebamowo; Ananyo Choudhury; Jean-Tristan Brandenburg; Mogomotsi Matshaba; Gustave Simo; Francisco-Javier Gamo; Scott Hazelhurst
Journal:  medRxiv       Date:  2020-06-02

4.  G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.

Authors:  Jorge E B da Rocha; Houcemeddine Othman; Caroline T Tiemessen; Gerrit Botha; Michèle Ramsay; Collen Masimirembwa; Clement Adebamowo; Ananyo Choudhury; Jean-Tristan Brandenburg; Mogomotsi Matshaba; Gustave Simo; Francisco-Javier Gamo; Scott Hazelhurst
Journal:  Pharmacogenomics J       Date:  2021-07-23       Impact factor: 3.550

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.